Clinical Outcomes Between Pulsatile and Non-Pulsatile Flow During Cardiopulmonary Bypass
NCT ID: NCT07009730
Last Updated: 2025-06-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
80 participants
OBSERVATIONAL
2019-07-23
2020-07-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimizing Pulsatility During Cardiopulmonary Bypass
NCT05344573
Best Cardiac Output During Cardiopulmonary Bypass
NCT01379638
Cardiopulmonary Bypass (CPB) Pumps and Blood Activation
NCT00187967
Arrhythmia in on Pump vs. Off Pump Coronary Artery Bypass Grafting
NCT04093817
Exploration of Cerebral Pathophysiology During and After CABG Using CPB
NCT02941380
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cardiopulmonary bypass, pulsatile flow
Bypassing Agents
Cardiopulmonary bypass surgery, pulsatile flow
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bypassing Agents
Cardiopulmonary bypass surgery, pulsatile flow
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* • Patient with bleeding dysfunction;AKI ;deranged liver dysfunction\\
* • Patient/Surrogate decision maker not giving written informed consent
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tribhuvan University Teaching Hospital, Institute Of Medicine.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ishwor Thapaliya
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tribhuvan University Teaching Hospital, Institute of Medicine (IOM), Kathmandu, Nepal
Kathmandu, , Nepal
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20.7.2017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.